Literature DB >> 16475789

Formation of virus-like clusters is an intrinsic property of the tumor necrosis factor family member BAFF (B cell activating factor).

Teresa G Cachero1, Ian M Schwartz, Fang Qian, Eric S Day, Claudia Bossen, Karine Ingold, Aubry Tardivel, Dennis Krushinskie, John Eldredge, Laura Silvian, Alexey Lugovskoy, Graham K Farrington, Kathy Strauch, Pascal Schneider, Adrian Whitty.   

Abstract

The oligomeric state of BAFF (B cell activing factor), a tumor necrosis factor (TNF) family cytokine that plays a critical role in B cell development and survival, has been the subject of recent debate. Myc-tagged BAFF starting at residue Gln136 was previously reported to crystallize as trimers at pH 4.5, whereas a histidine-tagged construct of BAFF, starting at residue Ala134, formed a virus-like cluster containing 60 monomers when crystallized at pH 9.0. The formation of the BAFF 60-mer was pH dependent, requiring pH >or= 7.0. More recently, 60-mer formation was suggested to be artificially induced by the histidine tag, and it was proposed that BAFF, like all other TNF family members, is trimeric. We report here that a construct of BAFF with no amino-terminal tag (Ala134-BAFF) can form a 60-mer in solution. Using size exclusion chromatography and static light scattering to monitor trimer to 60-mer ratios in BAFF preparations, we find that 60-mer formation is pH-dependent and requires histidine 218 within the DE loop of BAFF. Biacore measurements established that the affinity of Ala134-BAFF for the BAFF receptor BAFFR/BR3 is similar to that of myc-Gln136-BAFF, which is exclusively trimeric in solution. However, Ala134-BAFF is more efficacious than myc-Gln136-BAFF in inducing B cell proliferation in vitro. We additionally show that BAFF that is processed and secreted by 293T cells transfected with full-length BAFF, or by a histiocytic lymphoma cell line (U937) that expresses BAFF endogenously, forms a pH-dependent 60-mer in solution. Our results indicate that the formation of the 60-mer in solution by the BAFF extracellular domain is an intrinsic property of the protein, and therefore that this more active form of BAFF may be physiologically relevant.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16475789     DOI: 10.1021/bi051685o

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  24 in total

Review 1.  Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways.

Authors:  Carl F Ware
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

2.  Structural conservation of druggable hot spots in protein-protein interfaces.

Authors:  Dima Kozakov; David R Hall; Gwo-Yu Chuang; Regina Cencic; Ryan Brenke; Laurie E Grove; Dmitri Beglov; Jerry Pelletier; Adrian Whitty; Sandor Vajda
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-01       Impact factor: 11.205

Review 3.  The Tumor Necrosis Factor Family: Family Conventions and Private Idiosyncrasies.

Authors:  David Wallach
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-10-01       Impact factor: 10.005

Review 4.  The BAFF/APRIL system in SLE pathogenesis.

Authors:  Fabien B Vincent; Eric F Morand; Pascal Schneider; Fabienne Mackay
Journal:  Nat Rev Rheumatol       Date:  2014-03-11       Impact factor: 20.543

Review 5.  TNF superfamily protein-protein interactions: feasibility of small- molecule modulation.

Authors:  Yun Song; Peter Buchwald
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

6.  Stoichiometry of Heteromeric BAFF and APRIL Cytokines Dictates Their Receptor Binding and Signaling Properties.

Authors:  Sonia Schuepbach-Mallepell; Dolon Das; Laure Willen; Michele Vigolo; Aubry Tardivel; Luc Lebon; Christine Kowalczyk-Quintas; Josquin Nys; Cristian Smulski; Timothy S Zheng; Klaus Maskos; Alfred Lammens; Xuliang Jiang; Henry Hess; Seng-Lai Tan; Pascal Schneider
Journal:  J Biol Chem       Date:  2015-05-07       Impact factor: 5.157

7.  Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID).

Authors:  Lilit Garibyan; Adrian A Lobito; Richard M Siegel; Matthew E Call; Kai W Wucherpfennig; Raif S Geha
Journal:  J Clin Invest       Date:  2007-05-10       Impact factor: 14.808

8.  Interferon-β therapy specifically reduces pathogenic memory B cells in multiple sclerosis patients by inducing a FAS-mediated apoptosis.

Authors:  Fabiana Rizzo; Elena Giacomini; Rosella Mechelli; Maria Chiara Buscarinu; Marco Salvetti; Martina Severa; Eliana Marina Coccia
Journal:  Immunol Cell Biol       Date:  2016-06-06       Impact factor: 5.126

Review 9.  Anti-B-Cell Therapies in Autoimmune Neurological Diseases: Rationale and Efficacy Trials.

Authors:  Harry Alexopoulos; Angie Biba; Marinos C Dalakas
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

10.  Structural basis for ligand-mediated mouse GITR activation.

Authors:  Zhaocai Zhou; Yukiko Tone; Xiaomin Song; Keiji Furuuchi; James D Lear; Herman Waldmann; Masahide Tone; Mark I Greene; Ramachandran Murali
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.